Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Virpax Pharmaceuticals Inc (EM) VRPX

Healthcare Biotechnology
Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical spray film delivery technology for osteoarthritis pain; Probudur... see more

Current News (EXPM:VRPX)

Virpax Pharmaceuticals Announces Reverse Stock Split

Business Wire March 19, 2025

Virpax Receives Positive Probudur(TM) Results for Dose Range Study Moves Towards Next Steps in IND

Business Wire March 18, 2025

Virpax Looking to Use MET to Develop Intranasal COVID Vaccine

Business Wire March 7, 2025

Virpax's NES100 to be Presented at The Society of Toxicology by NCATS

Business Wire March 5, 2025

Virpax Reports Positive Results in Human Study for its Molecular Envelope Technology

Business Wire February 27, 2025

Virpax Confirms Positive Results with US Army with Probudur(TM) for Combat Care Study

Business Wire February 13, 2025

Virpax's Matthew Barnes to Present at Outsourcing in Clinical Trials Conference

Business Wire January 31, 2025

Virpax Pharmaceuticals, Inc. Announces Closing of $6.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Business Wire January 30, 2025

Virpax Pharmaceuticals, Inc. Announces Pricing of $6 Million Public Offering of Common Stock and Pre-Funded Warrants

Business Wire January 28, 2025
View More News ››

Opinion & Analysis (EXPM:VRPX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (EXPM:VRPX)

VRPX...back to back NR's & vol & Price action

Me personally....wouldn't touch this with a 10 Ft pole U do u currently trading at ~ $0.93 on over 33 mil shs
Iseneschal - November 22, 2024

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX): Navigating the C

http://beyondspx.com/2024/08/02/virpax-pharmaceuticals-inc-nasdaqvrpx-navigating-the-challenges-of-a-preclinical-stage-pharmaceutical...
MikeTester - August 3, 2024

Buy buy buy

Looking fine after market buy at .27
Nibinator - December 14, 2023

📢📢📣📣📺FSD Pharma Inc CEO Anthony Durkacz (Nasdaq: HUGE)

<< View Post To Watch Video >>
LinethRamirez - August 23, 2021

FSD Pharma Inc CEO Anthony Durkacz (Nasdaq: HUGE)(CSE:HUGE)

<< View Post To Watch Video >>
LannieMich23 - August 19, 2021

VRPX....halted x's 3 & NR....on watch

Cheers !
Iseneschal - July 26, 2021
View more Bullboard ››

Pinnacle Silver and Gold Corp

Pinnacle Silver and Gold Corp

Pinnacle Silver and Gold Corp., an exploration stage company, engages in the acquisition and exploration of mineral ...
View More »